Peptide Initiative

Peptide profile · Immune

Thymopentin (TP-5)

Immune-boosting pentapeptide fragment that enhances T-cell function and dendritic cell maturation

Moderate human trialsResearch compound
30 seconds to few minutes in plasmaHalf-life
Sustained release via subcutaneous routeBioavailability
679.8Molecular weight

Molecular formula

C30H49N9O9

CAS number
69558-55-0
PubChem
451417
Developed · 1979
Gideon Goldstein, Memorial Sloan-Kettering Cancer Center / Immunobiology Research Institute

Amino acid sequence

Arg-Lys-Asp-Val-Tyr (RKDVY)

Immune EnhancementDirectly activates T-cells and dendritic cells to strengthen immune response and resistance to infection

8.5

Cardiovascular SupportImproves ejection fraction and exercise capacity while reducing harmful inflammatory cytokines in heart failure patients

7.5

Post-Recovery SupportRestores immune function after surgery or major stress by protecting critical immune signaling pathways

8.0

Ratings out of 10.

50mg

Every documented dose level

PhaseDoseFrequencyRoute
6 weeks to 48 weeks depending on indication50 mgThree times weeklySubcutaneous injection
Several weeks50 mg by slow IVRepeated injections (e.g. three times weekly)Intravenous injection
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for immune system strengthening & recovering from illness or surgery

Best for

  • Immune System Enhancement

    Thymopentin directly increases T-cell function and promotes dendritic cell maturation, making it ideal for people seeking to boost immune response naturally

  • Cardiac Health Support

    Clinical trials show thymopentin improves ejection fraction and exercise capacity in elderly heart failure patients while enhancing immune markers

  • Post-Surgery Recovery

    Helps restore immune function after major surgery and protects important immune responses during recovery period

Consider alternatives if

Immune system enhancementThymosin alpha-1 (more extensively studied)Thymosin beta-4 (different mechanism)Imugen (synthetic immune modulator)
T-cell supportThymopentin analog peptidesThymopoietin (parent peptide)
Cardiac functionCoQ10 supplementationNattokinase

Do not use if

  • Pregnant or breastfeeding
  • Severely immunocompromised without medical supervision
  • Allergic to peptide medications

Use with caution if

  • Taking immunosuppressive medications - consult healthcare provider
  • Recent live vaccine - wait at least 2 weeks
  • History of severe allergies - start with lower dose
  • On high-dose corticosteroids - may reduce effectiveness

Not sure?

Compare Thymopentin (TP-5) with similar peptides to find the best fit for your goals.

Route

Subcutaneous (preferred) or Intravenous

Best sites

  • Abdomen (2 inches from navel)
  • Front of thighs
  • Outer upper arm (with assistance)
  • Rotate sites daily to prevent irritation

The Thymopentin (TP-5) injection guide covers reconstitution · step-by-step technique · storage · a sample daily schedule.

3 common side effects · 3 serious

Emergency signs first, then what this page and MedlinePlus say.

Thymopentin is well-tolerated with minimal side effects reported in clinical trials.

Most adverse events are mild and local. No serious safety concerns have emerged from decades of clinical use in China and Europe.

Safety profile established through Phase 1-2 clinical trials in cardiac disease, rheumatoid arthritis, HIV, and burns. Dosages up to 100 mg/day IV studied without serious adverse effects.


Common side effects · experienced by some users

Local injection site reaction

Mild redness, swelling, or soreness at injection site lasting a few hours to a day

Management
Rotate injection sites, apply ice if needed, use proper injection technique

Mild fatigue

Temporary tiredness, usually transient as body adjusts to immune stimulation

Management
Rest, ensure adequate sleep, stay hydrated; typically resolves within days

Transient fever

Low-grade fever as immune system responds, usually 99-101°F

Management
Monitor temperature, stay hydrated, fever typically passes within 24 hours

Serious side effects

Allergic reaction

Severe allergic response including difficulty breathing or anaphylaxis (extremely rare)

Management
Seek emergency medical attention immediately, use epinephrine if available

Less commonMuscle achesMild headache

These typically resolve with continued use or dose adjustment.


Stop and seek help if

  • Severe allergic reaction or anaphylaxis
  • Persistent high fever above 102°F
  • Severe local injection site reaction with spreading infection signs
  • Signs of uncontrolled immune activation (severe fatigue, swollen lymph nodes)
  • Doctor's recommendation due to new medical condition

Consult healthcare provider before stopping treatment. Do not stop abruptly without medical guidance.


With other peptides

  • Thymosin alpha-1: May have additive immune effects; consult doctor
  • Thymosin beta-4: Different mechanism; can be combined with medical supervision
  • BPC-157: Can be combined; allow 2 hours between injections

With medications

  • Immunosuppressants: May reduce thymopentin effectiveness; consult doctor
  • Corticosteroids: High-dose steroids may reduce immune response benefits
  • Antiretrovirals: Thymopentin may enhance their effects in HIV patients

With supplements

  • Vitamin D: Synergistic immune effects
  • Zinc: Works well together for immune support
  • Probiotics: Combined benefit for immune health

Moderate human trials · first signs week 1

Evidence level

Moderate human trials

(Phase 1-2)

80/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)


How it works

Thymopentin is a tiny 5-amino acid peptide that is the active core of a larger immune protein called thymopoietin.

Think of it like extracting the most powerful part of an immune booster. When you inject it, your immune system's T-cells and dendritic cells wake up and work better. Your body also produces more immune chemicals that fight inflammation and protect health.

It's especially helpful for immune recovery after surgery or stress.

The deeper mechanism

Thymopentin (TP-5) is a pentapeptide (5-amino acid) fragment corresponding to residues 32-36 of thymopoietin (Arg-Lys-Asp-Val-Tyr).

Despite its very short plasma half-life of 30 seconds to minutes, subcutaneous administration provides sustained immunomodulatory effects through multiple mechanisms: (1) T-cell activation and proliferation via increased cGMP signaling; (2) Dendritic cell maturation marked by upregulation of CD40, CD80, CD86, CD83, and MHC Class II; (3) Enhanced IL-12 and TNF-α production by mature dendritic cells; (4) Increased CD4+ T-cell proliferation driven by activated dendritic cells; (5) Modulation of inflammatory cytokines with increased IL-10 (anti-inflammatory) and reduced TNF-α, IL-1β (pro-inflammatory).

These effects make it useful in immune deficiency states, post-surgical recovery, and certain autoimmune conditions. The peptide retains full immunological activity despite being only 5 amino acids due to conformational specificity of the active epitope.


What to expect

  1. Week 1

    What you might notice

    • Possible mild injection site reaction
    • Body adjusting to immune stimulation
    • Possible transient mild fatigue

    What's normal

    • Mild redness at injection site for few hours
    • Low-grade temperature elevation
    • Slight soreness at injection area

    What's next

    • Continue with standard dosing
    • Rotate injection sites
    • Monitor for any persistent reactions
  2. Weeks 2-4

    What you might notice

    • Improved energy and recovery
    • Better sleep quality
    • Enhanced sense of well-being
    • Faster wound healing if applicable

    What's normal

    • Occasional mild fatigue as immune system strengthens
    • Transient mild fever response
    • Continued local site reactions with proper rotation

    What's next

    • Assess tolerance and effectiveness
    • Can increase to 2 mg if desired and well-tolerated
    • Continue daily injections as planned
  3. Weeks 5-6

    What you might notice

    • Noticeable improvement in immune markers if tested
    • Better resistance to minor infections
    • Sustained energy improvements
    • Enhanced athletic recovery

    What's normal

    • Minimal side effects by week 5-6
    • Consistent injection site responses
    • Body fully adapted to peptide

    What's next

    • Complete the 4-6 week cycle as planned
    • Consider 2-4 week break before next cycle
    • Retest immune markers if desired

Signs it's working

Immune markers

  • Increased CD3+ and CD4+ T-cell counts
  • Enhanced white blood cell function
  • Improved response to vaccines
  • Better immune memory formation

Signs it's working

Physical improvements

  • Faster recovery from workouts
  • Quicker wound healing
  • Improved energy levels
  • Better sleep quality
  • Reduced susceptibility to colds

Not seeing results?

Common reasons

  • Improper injection technique - ensure you're using correct angle and depth
  • Not rotating injection sites - varies location daily to prevent tissue damage
  • Reconstituted peptide degraded - check for cloudiness, discoloration, or age
  • Expecting too-rapid results - immune changes take 1-2 weeks minimum
  • Combining with immunosuppressants - these reduce effectiveness significantly
  • Inadequate dosing or inconsistent schedule - maintain daily routine for best results

10 registered studies, 1 still enrolling.

10registered studies
1recruiting now
2phase 3 or 4
1with published results

By phase

Phase 3

2

Phase 2

2

Phase 1

1

No phase

5

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug

10

Records only

0

About 333 people took part in the studies that actually administered Thymopentin (TP-5). Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.


Most recent

  • NCT05978908 Phase 1Completed24 enrolled

    Phase1 First in Human Ascending Dose Study to Evaluate the Safety and Tolerability of FC-12738 in Health Adults

    Neurodegenerative Disease Research Inc

  • NCT06112041 Phase 2Not Yet Recruiting29 enrolled

    The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)

    Second Affiliated Hospital of Soochow University

  • NCT00460681 Phase 3Unknown220 enrolled

    Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

    Fudan University

See all 10 trials for Thymopentin (TP-5)

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Thymopentin (TP-5) is named as an intervention; studies that only mention it in passing are not.

What exactly is Thymopentin and where does it come from?

Thymopentin (TP-5) is a pentapeptide (5-amino acid chain) that was discovered in 1979 by Gideon Goldstein at Memorial Sloan-Kettering Cancer Center. It's the active core fragment of thymopoietin, a naturally occurring hormone that helps regulate immune function. The sequence is RKDVY (Arg-Lys-Asp-Val-Tyr), and despite being tiny, it contains all the immune-stimulating power of the larger parent protein.

Is Thymopentin FDA approved in the United States?

No, Thymopentin is not FDA approved in the United States. However, it has been approved and used clinically in China, Italy, and several other countries for decades. It has strong clinical data in cardiac disease, autoimmune conditions, and immune support. Always consult your healthcare provider about its use and legality in your jurisdiction.

How quickly does Thymopentin work?

You may notice initial effects within 1-2 weeks, such as improved energy and better sleep. However, significant immune marker improvements typically take 4-6 weeks of consistent daily use. Individual responses vary; some people notice changes within days while others need the full cycle to feel benefits.

Why is the half-life so short if it's effective?

Excellent question. While Thymopentin has a plasma half-life of only 30 seconds to a few minutes (it's quickly broken down by enzymes), when injected subcutaneously, it creates a depot effect that provides sustained release. Additionally, its effects on immune cells (T-cells and dendritic cells) trigger longer-lasting signaling cascades that continue long after the peptide itself is gone. So the peptide itself is brief, but its immune effects persist.

What are the most common side effects?

Most users experience minimal side effects. The most common are mild local reactions at the injection site (redness or soreness) and transient fatigue or low-grade fever in the first week as your immune system activates. These typically resolve quickly and are normal signs that the peptide is working. Serious side effects are extremely rare.

Can I combine Thymopentin with other immune peptides?

Yes, many people combine it with other immune-supporting peptides like Thymosin alpha-1 or with supplements like Vitamin D and Zinc. However, always allow 2 hours between different peptide injections, and consult your healthcare provider, especially if you're using immunosuppressive medications.

How do I know if my Thymopentin is still good after reconstitution?

A reconstituted solution should be clear and colorless. Do not use if the solution is cloudy, discolored (yellowing), has visible particles, or has an unusual odor. Once reconstituted, use within 24-48 hours when stored in the refrigerator. Always store in a sterile vial.

What's the difference between subcutaneous and intravenous injection?

Subcutaneous injections (under the skin) are easier to do at home and provide sustained release due to the depot effect. Intravenous (IV) injections go directly into the bloodstream and provide immediate effect but much shorter duration. Most people use subcutaneous for convenience and better sustained results.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Thymopentin (TP-5), on one page.

Thymopentin (TP-5) dosing protocol

Medical disclaimer

Thymopentin (TP-5) is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 9, 2026

50 mg Three times weekly · onset 1-2 weeks
Open the Thymopentin (TP-5) calculatorThymopentin (TP-5) calculator